Laparoscopic Augmented Reality for Identification of Liver Lesions - a Pre-clinical Randomized Cross-over Trial
LARA
Monocentric Prospective Randomized Study on the Influence of On-screen Use of a Virtual 3-dimensional Liver Model Reconstructed From CT Data on Spatial Perception During Laparoscopy on the Liver Phantom.
1 other identifier
interventional
72
1 country
1
Brief Summary
Procedure preparation and accurate knowledge of the specific anatomy is an integral part of performing minimally invasive procedures. Due to the complexity with high variability and the non-visibility of the vascular structures, the liver poses a particular challenge. Therefore medical students and experienced surgeons will receive standardized, structured training on liver anatomy, the use of laparoscopic ultrasound and the application and use of CT data sets and the virtual 3D liver model. This training will be evaluated by questionnaires. Both groups then carry out a series of localization exercises on an artificial liver phantom: tumor imitations, which are displayed in the image(3D virtaul mdoel or 2D-CT-Data-Set), have to be found in the liver phantom laparoscopically using ultrasound. In each round, different scenarios are worked on, once without and then with the support of the virtual 3D liver model. The virtual 3D model can be displayed directly on the laparoscopic monitor using a display software specially developed for the trial and can be manipulated by the subjects. The aim of the study is to provide evidence that the availability and use of a virtual 3D model (augmented reality) leads to a significantly improved spatial perception of the subjects during laparoscopy of the liver. In addition, the subjectively perceived cognitive load of the subjects during the test run with and without the support of the virtual 3D model is surveyed and the learning success is evaluated.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 19, 2022
CompletedFirst Posted
Study publicly available on registry
May 25, 2022
CompletedStudy Start
First participant enrolled
September 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2024
CompletedAugust 16, 2022
August 1, 2022
1.2 years
May 19, 2022
August 14, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Number of correctly identified targets
The number of correctly spatially identified targets (tumors in the liver phantom)
immediately after tasks are performed, Day 1
Time required
The time required to localize the specified target structures (tumors in the live phantom)
immediately after tasks are performed, Day 1
Secondary Outcomes (3)
Task Load Index
immediately after tasks are performed, Day 1
Modification of procedure planning
immediately after tasks are performed with both methods, Day 1
Learning curve
immediately after tasks are performed with both methods, Day 1
Study Arms (2)
Method A
EXPERIMENTALSubjects in this arm will perform the task on the liver phantom with Method A (2D-CT). Then they will do the NASA task load index questionnaire. After that they will perform the tasks with Method B (2D-CT + 3D augmented reality model). After that again a NASA Task load index questionnaire is performed
Method B
EXPERIMENTALSubjects in this arm will perform the task on the liver phantom with method B (2D-CT + 3D augmented reality model). Then they will do the NASA task load index questionnaire. After that they will perform the tasks with Method A (2D-CT). After that again a NASA Task load index questionnaire is performed
Interventions
The subjects will perform tasks on the liver phantom (identification of target lesions). They will perform the tasks with Method A (2D-CT) or Method B (2D-CT + 3D augmented reality model). the intervention type Method A means that the trainings set up is performed first with Method A an after that with Method B.
The subjects will perform tasks on the liver phantom (identifikation of target lesions). They will perform the tasks with Method A (2D-CT) or Method B (2D-CT + 3D augmented reality model). the intervention type Method B means that the trainings set up is performed first with Method B an after that with Method A.
Eligibility Criteria
You may qualify if:
- medical student of University of Cologne OR medical doctor in a surgical specialty
- informed consent signed
You may not qualify if:
- known and not correctable deficit of stereoscopic view
- for medical students: experience with laparoscopy or laparoscopy simulators
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Cologne, Department of General, Visceral and Cancer Surgery
Cologne, 50931, Germany
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Roger Wahba, MD, PHD
Universitätsklinikum Köln
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- OTHER
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Priv.-Doz. Dr. med Roger Wahba
Study Record Dates
First Submitted
May 19, 2022
First Posted
May 25, 2022
Study Start
September 1, 2022
Primary Completion
December 1, 2023
Study Completion
March 1, 2024
Last Updated
August 16, 2022
Record last verified: 2022-08
Data Sharing
- IPD Sharing
- Will not share